Prospective comparison of 18F-FDG PET/MRI and 18F-FDG PET/CT for thoracic staging of non-small cell lung cancer.
Julian KirchnerLino M SawickiFelix NensaBenedikt M SchaarschmidtHenning ReisMarc IngenwerthSimon BognerClemens AignerChristian BuchbenderLale UmutluGerald AntochKen HerrmannPhilipp HeuschPublished in: European journal of nuclear medicine and molecular imaging (2018)
18F-FDG PET/MRI and 18F-FDG PET/CT show an equivalently high diagnostic performance for T and N staging in patients suffering from NSCLC.
Keyphrases
- pet ct
- positron emission tomography
- pet imaging
- end stage renal disease
- computed tomography
- magnetic resonance imaging
- contrast enhanced
- lymph node
- ejection fraction
- newly diagnosed
- small cell lung cancer
- chronic kidney disease
- diffusion weighted imaging
- prognostic factors
- peritoneal dialysis
- magnetic resonance
- patient reported outcomes
- clinical evaluation